2,513
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China

, , , , , , , , , ORCID Icon, , & show all
Pages 1-10 | Received 10 Aug 2018, Accepted 21 Oct 2018, Published online: 16 Nov 2018

References

  • World Health Organization. in WHO Guidelines Approved by the Guidelines Review Committee (WHO, Geneva, 2015).
  • GegiaMWintersNBenedettiAvan SoolingenDMenziesDTreatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysisLancet Infect. Dis.201717 223 23410.1016/S1473-3099(16)30407-8
  • HeymBZhangYPouletSYoungDColeSTCharacterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosisJ. Bacteriol.19931754255425910.1128/jb.175.13.4255-4259.1993
  • ZhangYHeymBAllenBYoungDColeSThe catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature199235859159310.1038/358591a0
  • UnissaANSubbianSHannaLESelvakumarNOverview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosisInfect. Genet. Evol.20164547449210.1016/j.meegid.2016.09.004
  • SreevatsanSPanXZhangYDereticVMusserJMAnalysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localitiesAntimicrob. Agents Chemother.19974160060610.1128/AAC.41.3.600
  • BanerjeeAinhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosisScience199426322723010.1126/science.8284673
  • RamaswamySVSingle nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosisAntimicrob. Agents Chemother.2003471241125010.1128/AAC.47.4.1241-1250.2003
  • LeeASLimIHTangLLTelentiAWongSYContribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in SingaporeAntimicrob. Agents Chemother.1999432087208910.1128/AAC.43.8.2087
  • ZahrtTCSongJSipleJDereticVMycobacterial FurA is a negative regulator of catalase-peroxidase gene katGMol. Microbiol.2001391174118510.1111/j.1365-2958.2001.02321.x
  • ColangeliRThe Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutolMol. Microbiol.2005551829184010.1111/j.1365-2958.2005.04510.x
  • KumariRSaxenaRTiwariSTripathiDKSrivastavaKKRv3080c regulates the rate of inhibition of mycobacteria by isoniazid through FabDMol. Cell. Biochem.201337414915510.1007/s11010-012-1514-5
  • UnissaANVariants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from IndiaTuberculosis201710714414810.1016/j.tube.2017.07.014
  • WilsonMExploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridizationProc. Natl Acad. Sci. USA199996128331283810.1073/pnas.96.22.12833
  • LeeASTeoASWongSYNovel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolatesAntimicrob. Agents Chemother.2001452157215910.1128/AAC.45.7.2157-2159.2001
  • UptonAMArylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolismMol. Microbiol.20014230931710.1046/j.1365-2958.2001.02648.x
  • GeistlichMLosickRTurnerJRRaoRNCharacterization of a novel regulatory gene governing the expression of a polyketide synthase gene in Streptomyces ambofaciensMol. Microbiol.199262019202910.1111/j.1365-2958.1992.tb01374.x
  • SeifertMCatanzaroDCatanzaroARodwellTCGenetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic reviewPLoS One201510e011962810.1371/journal.pone.0119628
  • ZhaoYNational survey of drug-resistant tuberculosis in ChinaN. Engl. J. Med.20123662161217010.1056/NEJMoa1108789
  • HazbonMHPopulation genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosisAntimicrob. Agents Chemother.2006502640264910.1128/AAC.00112-06
  • BorrellSGagneuxSInfectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosisInt. J. Tuberc. Lung. Dis.20091314561466
  • CohenTSommersBMurrayMThe effect of drug resistance on the fitness of Mycobacterium tuberculosisLancet Infect. Dis.20033132110.1016/S1473-3099(03)00483-3
  • LarsenMHOverexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosisMol. Microbiol.20024645346610.1046/j.1365-2958.2002.03162.x
  • MorlockGPMetchockBSikesDCrawfordJTCookseyRC. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolatesAntimicrob. Agents Chemother.2003473799380510.1128/AAC.47.12.3799-3805.2003
  • MullerBinhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa?Int. J. Tuberc. Lung. Dis.201115344351
  • HuyenMNEpidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomesAntimicrob. Agents Chemother.2013573620362710.1128/AAC.00077-13
  • TorresJNNovel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolatesEmerg. Microbes Infect.2015410.1038/emi.2015.42
  • AbeCBiological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in JapanJ. Clin. Microbiol.2008462263226810.1128/JCM.00561-08
  • BrossierFBoudinetMJarlierVPetrellaSSougakoffWComparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosisTuberculosis2016100152410.1016/j.tube.2016.06.002
  • ShermanDRCompensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosisScience19962721641164310.1126/science.272.5268.1641
  • PowersLindaHillarAlexLoewenPeter C.Active site structure of the catalase-peroxidases from Mycobacterium tuberculosis and Escherichia coli by extended X-ray absorption fine structure analysisBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology200115461445410.1016/S0167-4838(00)00221-1
  • HicksNDClinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug toleranceNat. Microbiol.201831032104210.1038/s41564-018-0218-3
  • AnargyrosPAstillDSLimISComparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimensJ. Clin. Microbiol.19902812881291267921
  • YajkoDMColorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosisJ. Clin. Microbiol.19953323242327228403
  • LiHDurbinRFast and accurate short read alignment with Burrows-Wheeler transformBioinformatics2009251754176010.1093/bioinformatics/btp324